Find and Pitch Jounalists, Get Your Story Covered

Tags: MDMA ecstasy PTSD therapy chevrolet veruca salt

	Profile	Recent Articles on Subject
1	Ashley Gallagher, Associate Editor Pharmacy Times One of Cabra girls on GoggleboxIRL. Dublin City, Ireland televisionentertainment	FDA Approves Tislelizumab in Combination With Chemotherapy for Gastric, Gastrosophageal Junction Adenocarcinoma - 20 days ago FDA Approves Amivantamab-Vmjw and Lazertinib for First-Line Treatment of NSCLC - 5 months ago FDA Grants Orphan Drug Designation to PT217 for Neuroendocrine Carcinoma - 5 months ago FDA Approves Macitentan, Tadalafil Combination Tablet for PAH - 10 months ago AstraZeneca to Initiate Trial for Triple-Combination Inhaled Therapy for Chronic Obstructive Pulmonary Disease - 10 months ago FDA Grants Fast Track Designation to Bepirovirsen for Chronic Hepatitis B - 11 months ago Combination Therapy Reduces Blood Pressure for Those Taking Ibrutinib - 12 months ago Celltrion Seeks Approval From FDA for CT-P47 as Biosimilar of Tocilizumab - 12 months ago
2	Greg Laub MedPage Today Director of Video at MedPage Today. Screenwriter, previous managing editor. videographyscreenwritingediting	Mezigdomide Combinations Show Promise in Multiple Myeloma - 26 days ago Novel Combination Active in Large B-Cell Lymphoma, Even After CAR-T - about 1 year ago Novel Doublet Highly Effective in Low-Grade Serous Ovarian Cancer - about 1 year ago Ubamatamab Shows Some Activity in Recurrent Ovarian Cancer - about 1 year ago Anti-TIGIT Drug Fails to Lift Response Rates in Cervical Cancer Trial - about 1 year ago
3	Ed Silverman STAT News Pharmalot columnist. Senior writer at STATnews. pharmaceutical industry	STAT+: Pharmalittle: We’re reading about unsupported drug price hikes, an annual HIV prevention shot, and more - about 1 month ago
4	Ian Ingram MedPage Today Deputy Managing Editor. MedPage Today. New York, New York medical journalismediting	Novel BTK Inhibitor Succeeds in Heavily Pretreated Immune Thrombocytopenia - about 1 month ago JAK1 Inhibitor Shows 'Remarkable' Activity in T-Cell Lymphoma - about 1 year ago Lenvatinib-Pembrolizumab Combo Misses Goal in First-Line HCC Trial - about 1 year ago Non-Covalent BTK Inhibitor Approved for CLL - about 1 year ago
5	Amir Ali, PharmD, BCOP Pharmacy Times Clinical Hem/Onc Pharmacist. USC Assistant Professor. Founder of OncologySolutionsRx. Los Angeles, CA Healthcareoncologypharmacyeducation	Challenges in Adopting Novel Therapies - 3 months ago Novel Drug Combinations in Precision Medicine Are an Emerging Landscape for Pharmacists - over 1 year ago
6	Alana Hippensteele, Managing Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey pharmacyhealthcarejournalism	Immunotherapy and Chemotherapy Combinations Show Promise for High-Risk HR+/HER2– Breast Cancer - 3 months ago Neoadjuvant Pembrolizumab Plus Chemotherapy Followed by Adjuvant Pembrolizumab Is New Standard of Care for High-Risk Early-Stage TNBC - 4 months ago Managing Adverse Event Profiles for Three Bispecific Antibodies Approved for Lymphoma - 10 months ago Ibrutinib Plus Venetoclax With MRD-Directed Duration of Treatment Is a New Standard-of-Care Regimen for Previously Unmanaged CLL - 12 months ago
7	Meagan Parrish Pharma Voice Senior editor @industrydive. Pharma world follower. Wisconsin, USA pharmaceuticalsjournalismparenting	An Alzheimer’s drugmaker is accused of data ‘manipulation.’ Should its trials be stopped? - 4 months ago
8	Kennedy Ferruggia, Assistant Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey pharmacyhealthcarejournalism	FDA Grants Regenerative Medicine Advanced Therapy Designation for OBX-115 - 5 months ago Study: mRNA Combination Vaccine Provides Protection Against COVID-19 and Influenza - 5 months ago 2-Drug Regimen Shows Comparable Effectiveness With 3-Drug Regimen to Treat HIV-1 - 6 months ago Jazz Pharmaceuticals Submits Biologics License Application for Zanidatamab to Treat Biliary Tract Cancer - 10 months ago
9	Matthew Herper STAT News Writes at STAT. Biology's century. Undisclosed biologydatajournalism	STAT+: Pfizer and BioNTech effort to develop Covid-influenza combination vaccine sees setback - 5 months ago
10	Mike Bassett MedPage Today Explains healthcare complexities. Not endorsements. New York, New York Healthcare journalism	Immunotherapy Combo Active in Advanced PD-L1-Negative HNSCC - 6 months ago Chemotherapy/ICI Combos Falter as Second-Line Treatment for Gastric Cancer - 10 months ago PD-1 Inhibitor Plus Chemotherapy Shows Promising Activity in Rare Lymphoma - 10 months ago FDA Approves Antibiotic Combination for Complicated UTIs - 11 months ago All-Oral Therapy Promising in Higher-Risk MDS, CMML - 12 months ago Cabozantinib Plus Atezolizumab Delays Progression in mCRPC - 12 months ago Antibody-Drug Conjugate Improves PFS in Pretreated Breast, Lung Cancers - about 1 year ago

Journalists covering Investigational Combination Therapy